Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Meropenem - Vaborbactam
2. Meropenem And Vaborbactam
3. Meropenem Vaborbactam Drug Combination
4. Vabomere
1. Meropenem & Vaborbactam
2. Meropenem + Vaborbactam
3. 2031124-72-6
4. Vabomere
5. Meropenem / Vaborbactam
6. Meropenem And Vaborbactam
7. Meropenem Mixture With Vaborbactam
8. (4r,5s,6s)-3-[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid;2-[(3r,6s)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic Acid
Molecular Weight | 680.6 g/mol |
---|---|
Molecular Formula | C29H41BN4O10S2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 10 |
Exact Mass | 680.2357160 g/mol |
Monoisotopic Mass | 680.2357160 g/mol |
Topological Polar Surface Area | 260 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 1050 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DH - Carbapenems
J01DH52 - Meropenem and vaborbactam
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?